Characteristics of Tuberculosis Infection in Rheumatic Disease

Retrospective Analysis of Tuberculosis in Rheumatic Diseases for Epidemiology, Risk Factors, Disease Presentation, Complications, Treatment, and Prognosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03736278

Enrollment

Registered

2018-11-09

Start date

2018-11-10

Completion date

2019-09-24

Last updated

2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Diseases, Tuberculosis

Brief summary

A retrospective study evaluating the characteristics of tuberculosis infection in patients of rheumatic disease.

Interventions

OTHERNo intervention

We group the patients according to the outcome (survival vs mortality)

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* The patients with International Classification of Diseases (ICD) codes of rheumatic diseases during 2006-2017 * Definite evidence of tuberculosis infection

Exclusion criteria

* HIV, malignancy, not follow-up rheumatic disease in National Taiwan University Hospital, younger than 20-year-old, refusing attend research

Design outcomes

Primary

Measure	Time frame	Description
Mortality	approximately 6 months	Death of any cause (The definition of TB mortality from WHO is death of any cause during TB treatment.)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026